Investview (INVUP) Cash & Equivalents (2010 - 2026)

Investview (INVUP) has 17 years of Cash & Equivalents data on file, last reported at $4.5 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $4.5 million, down 74.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (down 74.14% YoY), and the FY2025 annual result was $10.0 million, down 55.53% from the prior year.
• Cash & Equivalents slipped to $4.5 million in Q1 2026 per INVUP's latest filing, from $10.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $24.9 million in Q1 2022 and troughed at $4.5 million in Q1 2026.
• A 5-year average of $19.2 million and a median of $20.6 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents jumped 361.37% in 2022, then plunged 74.14% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $20.3 million in 2022, then rose by 2.93% to $20.9 million in 2023, then climbed by 7.44% to $22.5 million in 2024, then sank by 55.53% to $10.0 million in 2025, then sank by 54.72% to $4.5 million in 2026.
• Business Quant data shows INVUP's Cash & Equivalents at $4.5 million in Q1 2026, $10.0 million in Q4 2025, and $15.1 million in Q3 2025.